ORPHAZYME A/S - ADR (ORPH) Forecast, Price Target & Analyst Ratings

NASDAQ:ORPH

Current stock price

0.87
-0.02 (-2.25%)
At close:
0.8002
-0.07 (-8.02%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ORPHAZYME A/S - ADR (ORPH).

Forecast Snapshot

Consensus Price Target

Price Target
$15.81
+ 1,717.72% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q3 / 2021
EPS Estimate
-$3.86
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
37.78%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$15.81
Upside
+ 1,717.72%
From current price of $0.87 to mean target of $15.81, Based on 9 analyst forecasts
Low
$15.66
Median
$15.81
High
$16.28

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for ORPH. The average price target is 15.81 null. This implies a price increase of 1717.72% is expected in the next year compared to the current price of 0.87.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ORPH Current Analyst RatingORPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ORPH Historical Analyst RatingsORPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
37.78%
ORPH was analyzed by 9 analysts. The buy percentage consensus is at 38. So analysts seem to be rather negative about ORPH.
In the previous month the buy percentage consensus was at a similar level.
ORPH was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q3 / 2021
EPS Estimate
-$3.86
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2021 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
ORPH revenue by date.ORPH revenue by date.
N/AN/A
-37.14%		N/A
204.55%		N/A
78.35%		N/A
83.70%
EBITDA
YoY % growth
ORPH ebitda by date.ORPH ebitda by date.
-29.236M-62.814M
-114.85%		-130.415M
-107.62%		-230.286M
-76.58%		-332.151M
-44.23%		-603.334M
-81.64%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
ORPH ebit by date.ORPH ebit by date.
-29.522M-63.52M
-115.16%		-131.042M
-106.30%		-231.652M
-76.78%		-335.954M
-45.03%		-608.534M
-81.14%		N/AN/AN/AN/AN/A
Operating Margin
ORPH operating margin by date.ORPH operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ORPH eps by date.ORPH eps by date.
N/AN/AN/AN/A
-67.59%		N/A
-25.87%		N/A
-14.75%		N/A
18.09%		N/A
-46.73%		N/A
-0.41%		N/A
25.80%		N/A
23.57%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 21 Q4 / 21 Q4 / 22
EPS
Q2Q % growth		-3.86-3.65
81.47%		-9.48
-159.89%
Revenue
Q2Q % growth		307.545M
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ORPH Yearly Revenue VS EstimatesORPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 50M 100M 150M 200M
ORPH Yearly EPS VS EstimatesORPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-6.47%
EPS Next 5 Year
5.64%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ORPHAZYME A/S - ADR / ORPH Forecast FAQ

What do analysts expect the price target to be for ORPHAZYME A/S - ADR (ORPH)?

9 analysts have analysed ORPH and the average price target is 15.81 null. This implies a price increase of 1717.72% is expected in the next year compared to the current price of 0.87.

Can you provide the consensus estimates for ORPHAZYME A/S - ADR next earnings?

The consensus EPS estimate for the next earnings of ORPHAZYME A/S - ADR (ORPH) is -3.86 null and the consensus revenue estimate is 0 null.